Frederick Callori
Director/Board Member at ASTRIA THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Profile
Frederick P.
Callori is currently serving as an Independent Director at Astria Therapeutics, Inc., Director at CereVasc, Inc., Director at Quellis Biosciences LLC, Director at Zucara Therapeutics, Inc., and Director at Polycore Therapeutics, Inc. He is also a Partner & Venture (PXV Fund) at Perceptive Advisors (Private Equity) since 2018 and an Executive Vice President at Xontogeny LLC since 2017.
Previously, he worked as an Independent Director at Landos Biopharma, Inc. from 2021 to 2024 and as a Partner at Choate, Hall & Stewart LLP from 1998 to 2017.
Mr. Callori obtained his undergraduate degree from the State University of New York at Binghamton and his graduate degree from Boston University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LANDOS BIOPHARMA, INC.
-.--% | 2024-05-22 | 0 ( -.--% ) | - $ | 2024-04-29 |
| 2024-04-08 | 0 ( -.--% ) | - $ | 2024-04-29 |
Frederick Callori active positions
| Companies | Position | Start |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Director/Board Member | 2021-01-27 |
CereVasc, Inc.
 CereVasc, Inc. Medical SpecialtiesHealth Technology CereVasc, Inc. engages in healthcare services. Ito focuses on the development of novel, minimally invasive treatments for patients with neurological diseases. The company was founded by Dan Levangie, Patrick Sullivan, Carl Heilman, and Adel Malek and is headquartered in Auburndale, MA. | Director/Board Member | - |
Xontogeny LLC
 Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Corporate Officer/Principal | 2022-12-31 |
Zucara Therapeutics, Inc.
 Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Director/Board Member | - |
Quellis Biosciences LLC
 Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Quellis Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Boston, MA. | Director/Board Member | - |
Polycore Therapeutics, Inc.
 Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | Director/Board Member | - |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Private Equity Investor | 2017-12-31 |
Former positions of Frederick Callori
| Companies | Position | End |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Director/Board Member | 2024-05-22 |
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Corporate Officer/Principal | 2017-07-31 |
Training of Frederick Callori
| Boston University School of Law | Graduate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Private companies | 7 |
|---|---|
CereVasc, Inc.
CereVasc, Inc. Medical SpecialtiesHealth Technology CereVasc, Inc. engages in healthcare services. Ito focuses on the development of novel, minimally invasive treatments for patients with neurological diseases. The company was founded by Dan Levangie, Patrick Sullivan, Carl Heilman, and Adel Malek and is headquartered in Auburndale, MA. | Health Technology |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Health Technology |
Choate, Hall & Stewart LLP
Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Commercial Services |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Health Technology |
Quellis Biosciences LLC
Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Quellis Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Boston, MA. | Health Technology |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Finance |
- Stock Market
- Insiders
- Frederick Callori
